| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.003 |